genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
Coronavirus
Immunai Expands from Observational to Functional Genomics
Antibody Drug Conjugates
RNA in Its DNA: Avidity Biosciences Combines mAb Selectivity, Oligonucleotide Precision
Bioprocessing
OliX Advancing in Nucleic Acid Therapeutics
News
Drug Discovery
ICON to Acquire PRA for $12B, as COVID-19 Spurs CRO Consolidation
Artificial Intelligence
AI Joins Forces with fMRI to Decode Brain Dynamics Underlying Neurofeedback
Neuroscience
First Compound That Potentially Halts Degeneration of Neurons in ALS Identified
Aging
Scientists Identify Mechanism Linking Exercise with Bone Strength and Immunity
Biomarkers
Genetic Method Improves Estimating Prostate Cancer Risk in Multi-Ethnic Groups
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
Bioprocessing
People Are Key to the Digital Evolution of Biopharma
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Drug Discovery
ICON to Acquire PRA for $12B, as COVID-19 Spurs CRO Consolidation
Biomarkers
Genetic Method Improves Estimating Prostate Cancer Risk in Multi-Ethnic Groups
Cancer
Blocking a Treg Mechanism Can Scorch Tumors without Stoking Autoimmunity
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Magazine
December 1 2007 Vol. 27 No. 21
December 1 2007 Vol. 27 No. 21
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
December 1 2007 Vol. 27 No. 21
Novozymes Tackles Ingredient Manufacture
December 1 2007 Vol. 27 No. 21
Lyophilization Advances Improve Recovery
December 1 2007 Vol. 27 No. 21
Industry on Target for a Successful Year
December 1 2007 Vol. 27 No. 21
Enlisting CROs for Clinical Trial Assistance
December 1 2007 Vol. 27 No. 21
Biomarket Trends: LIMS Growth Driven by Replacement Purchases
December 1 2007 Vol. 27 No. 21
Assay: Analyzing Lipid-Modifying Enzymes
December 1 2007 Vol. 27 No. 21
Finding Your Place as an Industry Scientist
December 1 2007 Vol. 27 No. 21
High-Performance Melting Curve Analysis
December 1 2007 Vol. 27 No. 21
Antisocial Bio-Activism
December 1 2007 Vol. 27 No. 21
Patent Ambushing Sullies Standard Setting
December 1 2007 Vol. 27 No. 21
Optimization of Electroporation Parameters
December 1 2007 Vol. 27 No. 21
Planning and Designing Biopharma Plants
December 1 2007 Vol. 27 No. 21
Biotech Aims High in the Lone Star State
December 1 2007 Vol. 27 No. 21
Erecting Exclusivity Barriers with Innovation
December 1 2007 Vol. 27 No. 21
ADMET Issues Slow Discovery
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
